Download the photo of (part of) the group during the conference in a higher resolution file
and the Program-Abstract book .
Tuberculosis remains an enormous burden to human health,
even at the beginning of the 21st century. The situation is worsening in many countries,
particularly due to the synergy with the HIV epidemic and the appearance of multi-drug resistant (MDR)
or extensively-drug resistant (XDR) tuberculosis. The urgently needed development of new tools that
can improve the diagnosis, prevention and/or therapy of tuberculosis and other major mycobacterial
diseases depends largely on the progress made by basic and applied research.
The EMBO conference series "Tuberculosis 2012" was an international congress that
provided a premium forum for the
discussion and exchange of the recent advances of current research and novel trends
related to tuberculosis, its causative agent Mycobacterium tuberculosis and related
pathogenic mycobacteria. This international meeting was held from
September 11-15, 2012, in the
Conference centre (CIS) within the campus of the Institut Pasteur.
There were more than 600 scientists attending the meeting.
Pedro ALZARI (IP, Paris), Clifton BARRY (NIAID, NIH, Bethesda),
Roland BROSCH (IP, Paris), Stewart COLE (EPFL, Lausanne), Sabine EHRT (Cornell University, New York),
Laurent FRAISSE (Sanofi-Aventis, Toulouse), Brigitte GICQUEL (IP, Paris), and
Valerie MIZRAHI (MRC, University of Cape Town).
Pedro ALZARI (Paris), Marco BELLINZONI (Paris),
Roland BROSCH (Paris), Carmen BUCHRIESER (Paris),
Laleh MAJLESSI (Paris), and Ludovic TAILLEUX (Paris).